The purification of triethylenetetramine and its dihydrochloride for the treatment of Wilson's disease

Journal of Chemical Research

Volumn , Issue 4, 2005, Pages 233-235

  Purchase, Rupert ^a  

^a NONE   (United Kingdom)

Author keywords

Amines; Ligands; Trientine; Wilson's disease

Indexed keywords

1,4 PIPERAZINEDIETHANAMINE; CHLORIDE; ETHYLENEDIAMINE DERIVATIVE; N [2 (1 PIPERAZINYL)ETHYL] 1,2 ETHANEDIAMINE; N,N BIS(2 AMINOETHYL) 1,2 ETHANEDIAMINE; PIPERAZINE DERIVATIVE; TRIENTINE; UNCLASSIFIED DRUG;

ARTICLE; DRUG PURIFICATION; DRUG SYNTHESIS; METHODOLOGY; WILSON DISEASE;

EID: 20944434388     PISSN: 03082342     EISSN: None     Source Type: Journal    
DOI: 10.3184/0308234054213375     Document Type: Article

References (47)

1. (a) Beilsteins Handbuch der Organischen Chemie, 4th edn, E III 4, p. 542;
2. (b) D.A. House, in Comprehensive Coordination Chemistry, eds G. Wilkinson, R.D. Gillard and J.A. McCleverty, Pergamon, Oxford, 1987, Vol. 2, pp. 23-72.
3. (a) J.M. Walshe, in Metabolic and Deficiency Diseases of the Nervous System. Part 1 (Handbook of Clinical Neurology, Vol. 27), eds P.J. Vinken and G.W. Bruyn, North-Holland Publishing Company, Amsterdam, 1976, pp 379-414;
4. (b) I.H. Scheinberg and I. Sternlieb, Wilson's Disease, W.B. Saunders, Philadelphia, 1984;
5. (c) T.U. Hoogenraad, Wilson's Disease, W.B. Saunders, London, 1996;
6. (d) G.J. Brewer, Wilson's Disease: A Clinician's Guide to Recognition, Diagnosis, and Management, Kluwer Academic, Boston, 2001;
7. (e) V.C. Culotta and J.D. Gitlin, in The Metabolic & Molecular Bases of Inherited Disease, 8th edn, eds. C.R. Scriver, A.L. Beaudet, W.S. Sly and D. Valle, McGraw-Hill, New York, 2001, pp 3105-3126.
8. J.M. Walshe, Lancet, 1969, ii, 1401.
9. Martindale The Complete Drug Reference, 3rd edn, ed. S.C. Sweetman, Pharmaceutical Press, London, 2002, p. 1025.
10. (a) J.M. Walshe, in The Management of Genetic Disorders, eds C.J. Papadatos and C.S. Bartsocas, Alan R. Liss, New York, 1979, pp 271-280;
11. (b) J.M. Walshe, Lancet, 1982, i, 643;
12. (c) J.M. Walshe, in Biological Aspects of Metals and Metal-Related Diseases, ed. B. Sarkar, Raven Press, New York, 1983, pp 243-261;
13. (d) T. Dahlman, P. Hartvig, M. Löfholm, H. Nordlinder, L. Lööf and K. Westermark, Quart. J. Med., 1995, 88, 609;
14. (e) P. Ferenci, Aliment. Pharmacol Ther., 2004, 19, 157.
15. J.M. Walshe, Quart. J. Med., 1973, 42, 441.
16. S.H. Laurie and B. Sarkar, J. Chem. Soc., Dalton Trans., 1977, 1822.
17. (a) L. Bergstedt and G. Widmark, Acta Chem. Scand., 1970, 24, 2713;
18. (b) The Dow Chemical Co., Texas, U.S.A., personal communication;
19. H.L. Spell, Anal. Chem., 1969, 41, 902.
20. The United States Pharmacopeia 28th Revision, United States Pharmacopeial Convention, Rockville, MD, 2005.
21. (a) R.S. Dubois, D.O. Rodgerson, T.L. Slovis, K.M. Hambidge and T.A. Bianchi, Lancet, 1970, ii, 775;
22. (b) H.B.F. Dixon, K. Gibbs and J.M. Walshe, Lancet, 1972, i, 853;
23. I. Bucur and K.H. Hasselgren, Lancet, 1975, ii, 1218;
24. H. Harders and E. Cohnen, Proc. Roy. Soc. Med., 1977, 70, Supplement 3, 10;
25. (e) J. Korbl, F. Jancik and V. Rabek, Rozvoj Farm. Ramci Ved.-Tech. Revoluce, Sb. Prednasek Sjezdu Cesk. Farm. Spol., 7th 1977 (Pub, 1979), 64-66;
26. Chem. Abstr., 1980, 93, 210354q;
27. (f) T. Suzuki, K. Sasabuchi, E. Sato and K. Unno, Byoin Yakugaku, 1987, 13, 335;
28. Chem. Abstr., 108, 192679;
29. (g) H. Fujito, M. Tasaki, M. Mori and K. Takata, Yakuzaigaku, 1990, 50, 402;
30. Chem. Abstr., 114, 234954.
31. (a) S. Lapanje, J. Haebig, H.T. Davis and S.A. Rice, J. Am. Chem. Soc., 1961, 83, 1590;
32. (b) J. Glerup, J. Josephsen, K. Michelsen, E. Pedersen and C.E. Schäffer, Acta Chem. Scand., 1970, 24, 247;
33. (c) I. Kuhr, M. Ferenc, J. Michalsky, M. Hruby, L. Strojil, L. Svobodova, J. Koerbl and F. Jancik, Czech. Pat. 197 093 (1982); Chem. Abstr., 1982, 96, 217226v;
34. (d) R. Menif and A.E. Martell, Inorg. Chem., 1989, 28, 116;
35. (e) W.L.F. Armarego and C.L.L. Chai, Purification of Laboratory Chemicals, Butterworth-Heinemann, Amsterdam, 5th edn, 2003, p 376.
36. (a) J.M. Walshe, in Orphan Drugs, ed. F.E. Karch, M. Dekker, New York, 1982, pp 58-71;
37. (b) J.M. Walshe, Lancet, 1970, ii, 154.
38. (a) G. Spielberger, Ger. Pat. 1 075 118 (1960); Chem. Abstr., 1961, 55, 12302;
39. (b) T. Ito, T. Nishi, H. Tsuchiya, and N. Tamamatsu, Jap. Pat. 71 03 364 (1971); Chem. Abstr., 1971, 75, 48409r;
40. (c) Aldrich Handbook of Fine Chemicals and Laboratory Equipment 2003-2004, product no. 25,953-5.
41. (a) S.P. Dagnall, D.N. Hague and M.E. McAdam, J. Chem. Soc., Perkin Trans. 2, 1984, 435;
42. (b) S.P. Dagnall, D.N. Hague and M.E. McAdam, J. Chem. Soc., Perkin Trans. 2, 1984, 1111.
43. L.-K. Ng, J. Chromatogr., 1984, 314, 455.
44. B.S. Furniss, A.J. Hannaford, P.W.G. Smith and A.R. Tatchell, Vogel's Textbook of Practical Organic Chemistry, Longman Scientific & Technical, Harlow, Essex, 5th edn, 1989, p 175.
45. (a) É.V. Ganin, V.F. Makarov and V.I. Nikitin, Zh. Org. Khim., 1987, 23, 370;
46. J. Org. Chem. USSR (Engl. Transl.), 1987, 23, 330;
47. (b) J. von Braun, O. Goll, E. Metz, Ber. Dtsch. Chem. Ges., 1926, 59, 2416.